1. Introduction {#sec1}
===============

Although cases of cardiac metastasis from uterine cervical carcinoma are occasionally recognized, they are rarely detected before death. Here, we present a case of suspected cardiac metastasis from uterine cervical squamous cell carcinoma. Systemic examinations were performed owing to a decrease in the patient\'s platelet count. Cardiac metastasis was later diagnosed on autopsy. This report describes this case together with the findings from other literatures.

2. Case Presentation {#sec2}
====================

The patient was a 27-year-old woman with four previous pregnancies resulting in two births and two abortions. She had no history of appreciable disease. She was diagnosed with class IIIa high-grade squamous intraepithelial lesion by a cervical smear conducted at 14 weeks of pregnancy and diagnosed with squamous cell carcinoma by punch biopsy. She was referred to our hospital at 16 weeks and 6 days of pregnancy for further examination and treatment. No clear macroscopic abnormality was recognized by colposcopy. She was admitted for conization at 18 weeks and 3 days of pregnancy. An exophytic papillary tumor was observed by colposcopy at the time of admission; it may have grown rapidly before admission. We fully explained to the patient and family members that the cancer had advanced and when the baby would be able to survive outside the uterus if the patient continued the pregnancy. The patient and her family desired surgical treatment and termination of the pregnancy. A radical hysterectomy with pelvic lymphadenectomy was conducted at 19 weeks and 0 days of pregnancy ([Figure 1](#fig1){ref-type="fig"}).

Postoperative pathological diagnosis revealed the following: uterine cervical carcinoma (pT1b1N1MX), squamous cell carcinoma with a keratinizing type, lymph vascular space positive for invasion, vaginal stump negative for invasion, and lymph nodes metastases (right external iliac lymph nodes, right inguinal lymph nodes, and right obturator lymph nodes).

Metastasis to the para-aortic lymph nodes was detected on positron emission tomography/computed tomography (PET-CT) performed postoperatively. Additional treatment options were discussed and explained. The patient and her family desired treatment that could be administered by visiting the hospital; therefore, chemotherapy was chosen. Weekly TN therapy (taxol 80 mg/m^2^, nedaplatin 25 mg/m^2^, i.v., once weekly) was conducted. Most of the metastases disappeared on PET-CT three months postoperatively and after the completion of nine cycles of chemotherapy. The medical effect of the treatment was judged as PR and chemotherapy was continued. FDG accumulation was noted in the left common iliac lymph nodes on PET-CT six months postoperatively and after the completion of 18 cycles of chemotherapy; this region also showed enlargement on CT. The medical effect of treatment was judged as PD, and chemotherapy was terminated. The treatment method was changed to radiation to the pelvis and para-aortic lymph nodes (whole pelvis: 1.8 Gy/fr, 5 fr/week, and 50.4 Gy; 2 Gy/fr for para-aortic lymph nodes to left common iliac lymph nodes, boosted to 10 Gy, 60.4 Gy in total) and the tumor shrunk. The patient did not desire additional medical treatment such as continued chemotherapy; therefore, we followed up the patient through outpatient visits without treatment.

FDG accumulation was recognized in the para-aortic lymph nodes and both common iliac lymph modes by PET-CT 10 months postoperatively (two months after the completion of radiation treatment). Although the patient had been informed about her condition, she was nearly asymptomatic; she and her family desired to continue follow-up on an outpatient basis.

Thereafter, she continued to undergo routine examinations and blood tests through outpatient visits, and her platelet count decreased. She was asymptomatic and desired follow-up visits. A remarkable decrease in platelet count from 32,000/*μ*L was observed in a blood test 15 months postoperatively (seven months after radiation treatment) ([Figure 2](#fig2){ref-type="fig"}). Although we attempted to persuade her to be hospitalized for detailed examination and treatment, she wished to be examined and treated through outpatient visits. Her PET-CT scan showed the FDG accumulations in the para-aortic lymph nodes and both common iliac lymph nodes remained nearly unchanged; however, an accumulation was detected in the left gluteus. Accumulations were detected in mediastinum and hilar lymph nodes as well, and metastases were suspected. Bone marrow examination revealed normal hematopoiesis, but the result was probably because of the idiopathic increase in platelet consumption. Multidetector CT showed a tumor extending from the right atrium to the right cardiac chamber (longest diameter, 10 cm).

The cardiovascular internal medicine department concluded that a medical procedure would be difficult. The cardiovascular surgery department was also consulted, and tumor removal by surgery was considered. However, careful judgment as to whether the patient\'s prognosis could be improved after surgical treatment was necessary. The patient and her family were fully informed about the above information and the possible risks of surgery; they did not desire surgery. Therefore, it was decided she would be followed up continuously.

On the 14th day after confirmation of the tumor, she was admitted to the hospital because of generalized weakness and difficulty with oral intake. Her general condition gradually worsened, and she died on the 21st day after confirmation of the tumor (488th day after the onset of initial treatment). Consent was obtained from the family to perform an autopsy. The findings were as follows: patient: a 28-year-old woman; clinical diagnosis: uterine cervical carcinoma; primary diagnosis:metastases of uterine cervical carcinoma (squamous cell carcinoma: status after the removal of the uterus, condition after chemoradiation therapy): heart, bilateral lungs, soft structure of the left gluteus, and lymph nodes (para-aortic lymph nodes, para-common iliac artery, and paratrachea);multiple microscopic tumor emboli and hemorrhagic infarctions of bilateral lungs (left: 382 g, right: 426 g).

A metastatic tumor (10 × 6 × 5 cm) extending from the right atrium to the pulmonary artery through the right ventricle was recognized; therefore, intracardiac tumor, tumor embolization, and tumor infarction of the lung periphery were thought to be the cause of death (Figures [3](#fig3){ref-type="fig"} [](#fig4){ref-type="fig"} [](#fig5){ref-type="fig"}--[6](#fig6){ref-type="fig"}).

3. Discussion {#sec3}
=============

Cases of cardiac metastasis from uterine cervical carcinoma are very rare; less than 40 of such cases have been reported in the literature ([Table 1](#tab1){ref-type="table"}).

Regarding cardiac tumors, metastatic tumors are 40 times more frequent than tumors originating from the cardiac region \[[@B1]\]. According to the autopsy results of cancer patients, the frequency of cardiac metastasis ranges from 1.5% to 21.8% \[[@B2], [@B3]\]. The primary tumors of cardiac metastases are often malignant melanoma, malignant lymphoma, leukemia, lung cancer, and breast cancer. Cases of gynecological malignancy are relatively infrequent \[[@B4], [@B5]\] and are rarely diagnosed before death \[[@B6]\]. The prognosis of a metastatic heart tumor is poor; the average life expectancy of patients with this diagnosis is less than six months.

We philologically discussed the cases in which cardiac metastases from uterine cervical carcinoma were found before death. Among the symptoms of 37 cases in which cardiac metastases were found before death, there were 30 (81.5%) cases in which chest symptoms were the most prevalent; among them, the following symptoms were common: sensation of dyspnea, 15/30 (50%); dyspnea, 13/30 (43.3%); chest pain, 10/30 (33.3%); and coughing, 6/30 (20.0%). Echocardiography was used for most diagnoses ([Table 1](#tab1){ref-type="table"}). In all, 29% of the cases were thought to be caused by cardiac metastases, and 16% cases developed cardiac tamponade as a clinical condition \[[@B4]\].

When a patient with uterine cervical carcinoma complains of chest symptoms, it is necessary to confirm the findings by echocardiographic examination and determine whether heart enlargement, an intracardiac space-occupying lesion, or pericardial effusion is present. If pericardial effusion, which could cause chest symptoms, is detected, it is necessary to conduct pericardial drainage and a pathological examination of punctual fluid simultaneously.

In our case, the patient had mild general malaise but only mild symptoms. Therefore, cardiac metastasis from uterine cervical carcinoma was detected through a detailed systemic examination performed because of decreased platelet count. In addition, the following cases were noted in the literature: an abnormality on electrocardiography performed for routine examination for bowel obstruction, a cardiac tumor detected through echocardiography, and a cardiac tumor incidentally detected on gallium scintigraphy performed to confirm the absence of pelvic suppuration as a cause of abdominal pain.

As for the immediate cause of death, cases in which tumor emboli of the lungs led to death have been reported, similar to our case \[[@B6], [@B7], [@B8]\]. If the emboli had been found and treated earlier, the symptoms could have been alleviated and the patient\'s prognosis could have been improved.

Although treatment focused on palliative care in our case, there have been cases in which open-heart surgery was performed and the patients survived for more than two years. Therefore, open-heart surgery is an option to improve survival \[[@B9], [@B10]\].

In cases of advanced uterine cervical carcinoma, in addition to systemic symptoms including chest symptoms, tumor marker increase, platelet count decrease, and hematogenous metastasis, it is useful to perform other tests such as measurement of D-dimer levels, echocardiography, and a detailed examination for cardiac metastasis using multidetector CT to improve the prognosis and alleviate symptoms.
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![Cervix at operation. The tumor is indicated by the arrow.](CRIOG2015-703424.001){#fig1}

![Tumor markers and platelet counts postoperatively. RH: radical hysterectomy, CT: chemotherapy, weekly TN (taxol 80 mg/m^2^, nedaplatin 25 mg/m^2^, i.v., once weekly), RT: radiation therapy whole pelvic 50.4 Gy, para-aortic lymphnode 60.4 Gy, SCC: squamous cell carcinoma-related antigen, and Plt: platelet.](CRIOG2015-703424.002){#fig2}

![Gross aspect of the heart at autopsy, showing the right ventricle containing the mass (arrow).](CRIOG2015-703424.003){#fig3}

![Cross section of the heart, showing tumor involvement of the right ventricle and pulmonary valve.](CRIOG2015-703424.004){#fig4}

![Microscopic view of the tumor, squamous cell carcinoma. Hematoxylin and eosin staining. Magnification ×400.](CRIOG2015-703424.005){#fig5}

![Pathophysiological changes until death.](CRIOG2015-703424.006){#fig6}

###### 

Cases of reported antemortem diagnosis of cardiac metastasis from cervical carcinoma.

  Year   Authors                Age   Stage   Symptoms                                 Diagnostic method                          Prognosis        Autopsy   References
  ------ ---------------------- ----- ------- ---------------------------------------- ------------------------------------------ ---------------- --------- --------------
  1967   Dibadj                 56    II      SOB                                      Autopsy                                    Uncertain        Yes       \[[@B11]\]
  1977   Charles et al.         46    IIIb    SOB                                      Biopsy                                     8 mo+            No        \[[@B12]\]
  1979   Ritcher and Yon        32    IIb     SOB                                      Echocardiogram                             15 d             Yes       \[[@B13]\]
  1980   Greenwald et al.       77    IIIb    Dyspnea, SOB, and weakness               Autopsy                                    5 d              Yes       \[[@B7]\]
  1981   Krivokapich et al.     32    IIIb    Chills, dyspnea, fever, and hemoptysis   Echocardiogram and operation               NS               Yes       \[[@B8]\]
  1984   Itoh et al.            64    IIb     SOB                                      Echocardiogram                             10 d             Yes       \[[@B14]\]
  1986   Hands et al.           43    Ib      Chest pain, lethargy, and nausea         ECG, echocardiogram, and operation         5 mo             No        \[[@B15]\]
  1987   Schaefer et al.        28    NS      Edema, SOB, and substernal heaviness     Echocardiogram                             2 d              Yes       \[[@B9]\]
  1990   Vargas-Barron et al.   55    NS      Aphasia and hemiparesis                  Echocardiogram and operation               3 mo+            No        \[[@B16]\]
  1990   Malviya et al.         37    IIIb    SOB                                      NS                                         3 mo             NS        \[[@B4]\]
  1990   Malviya et al.         42    IIIb    Chest pain, cough, dysplasia, and SOB    Biopsy, CT, and echocardiogram             5 d              NS        \[[@B4]\]
  1991   Lustig et al.          36    Ib      Chest pain                               Echocardiogram                             1 mo             No        \[[@B17]\]
  1992   Hsu et al.             36    Ib      Cough and dyspnea                        Biopsy and echocardiogram                  9 mo             NS        \[[@B18]\]
  1993   Kountz                 28    IIb     Ileus                                    Biopsy and echocardiogram                  3 mo             No        \[[@B19]\]
  1993   Nelson and Rose        51    IV      SOB                                      Biopsy and echocardiogram                  4 mo             No        \[[@B20]\]
  1993   Nelson and Rose        61    IIIb    Cough and dyspnea                        Biopsy and echocardiogram                  12 mo            No        \[[@B20]\]
  1995   Mohammed S et al.      64    IIIb    Dyspnea, SOB, and weakness               Echocardiogram                             3 d              Yes       \[[@B21]\]
  1997   Ando et al.            41    IIb     Abdominal pain and dyspnea               Biopsy, gallium scintigram, and MRI        5 mo             Yes       \[[@B22]\]
  1997   Batchelor et al.       43    IIb     VF                                       Biopsy and echocardiogram                  1 y+             No        \[[@B23]\]
  1997   Batchelor et al.       51    IIb     Chest pain and dyspnea                   Autopsy                                    NS               Yes       \[[@B23]\]
  1997   Batchelor et al.       65    NS      NS                                       Autopsy                                    NS               Yes       \[[@B23]\]
  1998   Lemus et al.           49    IVb     Dyspnea                                  CT and echocardiogram                      7 mo             No        \[[@B6]\]
  1998   Lemus et al.           53    Ib      Dyspnea                                  Echocardiogram and MRI                     1 mo             Yes       \[[@B6]\]
  1998   Shimotsu et al.        36    Ib      Precordial pain                          Biopsy, CT, ECG, echocardiogram, and MRI   NS               NS        \[[@B24]\]
  1999   Senzaki et al.         28    Ib      Chest pain and dyspnea                   Biopsy and echocardiogram                  Less than 1 mo   Yes       \[[@B5]\]
  2000   Harvey et al.          44    Ib      None                                     CT and echocardiogram                      8 mo+            No        \[[@B25]\]
  2001   Iwaki et al.           49    IVb     Cough, dyspnea, and fever                Biopsy and echocardiogram                  2 mo             Yes       \[[@B2]\]
  2004   Inamura et al.         58    Ib1     Chest pain, cough, and dyspnea           CT and echocardiogram                      4 mo             NS        \[[@B26]\]
  2005   Feys et al.            37    IIIb    Cough, fever, SOB, and sweating          Echocardiogram and PET/CT                  8 mo+            No        \[[@B27]\]
  2005   Saitoh et al.          68    IIIb    Palpitation and SOB                      Echocardiogram and operation               5 mo             NS        \[[@B3]\]
  2006   Nakao et al.           57    IIIb    Chest pain and dyspnea                   Echocardiogram                             2 mo             No        \[[@B10]\]
  2006   Ferraz et al.          63    NS      Dyspnea and fatigue                      Echocardiogram and operation               5 mo+            NS        \[[@B1]\]
  2007   Borsaru et al.         42    IVb     Chest pain and respiratory distress      CT, echocardiogram, and operation          NS               NS        \[[@B28]\]
  2010   Miller et al.          48    Ib2     Chest pain                               Biopsy and MRI                             8 mo             NS        \[[@B29]\]
  2010   Tomoko et al.          56    Ib2     None                                     CT, echocardiogram, and PET/CT             25 mo            No        \[[@B32]\]
  2013   Byun et al.            32    IIa2    Dyspnea and purpura of extremity         CT, echocardiogram, and operation          13 mo            NS        \[[@B31]\]
  2015   Okamoto et al.         27    Ib1     None                                     Multidetector computed tomography          21 d             Yes       Present case

NS: not stated, SOB: shortness of breath, VF: ventricular fibrillation, ECG: electrocardiogram, CT: computed tomography, PET/CT: positron emission computerized tomography, mo: months, and d: days.
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